Trademarkia Logo

Canada

C$
NASHNEXT
ADVERTISED

on 8 Jan 2025

Last Applicant/ Owned by

GENFIT, une société anonyme

885 avenue Eugène AvinéeParc Eurasanté59120 LOOS,

FR

Serial Number

2044414 filed on 6th Aug 2020

Correspondent Address

ROBIC AGENCE PI S.E.C./ ROBIC IP AGENCY LP

630, boul. René-Lévesque Ouest20e étageMontréal

QUÉBEC

CA

H3B1S6

NASHNEXT

Trademark usage description

diagnostic preparations for medical-scientific research use; chemical reagents for industrial use, other than for medical or veterinary purpose namely Read More

Classification Information


Class [001]
Diagnostic preparations for medical-scientific research use; Chemical reagents for industrial use, other than for medical or veterinary purpose namely, reagents used for analytical reagents determinations; diagnostic reagents for scientific research use that assess quantification assays ; diagnostic reagents for scientific research use that test for biomarkers in reagents ; Chemical reagents for scientific research purposes for use in diagnostic assays of liver disease.


Classification kind code

11

Class [005]
Pharmaceutical preparations for the prevention and treatment of liver diseases namely, non alcoholic related liver diseases: NAFLD (non alcoholic fatty liver disease) and non alcoholic steatohepatitis, liver fibrosis, hepatitis, cirrhosis, liver cancer, inherited diseases, primary biliary cirrhosis, primary sclerosing cholangitis, intrahepatic cholestasis, metabolic diseases and disorders, namely obesity, type 2 diabetes, stroke, heart disease and cardiovascular disease, gastrointestinal diseases, inflammatory bowel diseases, autoimmune diseases and cancers; Diagnostic preparations for medical purpose, for detecting metabolic disorders and liver diseases, being reagents, nucleotide sequences, enzymes, nucleotides for blood testing, reagents kit, biomarking agents, blood and blood plasma and serum products, all for medical purposes; diagnostic biomarker reagents for medical purposes;


Classification kind code

11

Class [009]
Software for the diagnosis of metabolic disorders and liver diseases namely non alcoholic related liver diseases: NAFLD (Non alcoholic fatty liver disease) and non alcoholic steatohepatitis, alcoholic related liver disease: alcoholic steato hepatitis, liver fibrosis, hepatitis, cirrhosis, liver cancer, inherited diseases, primary biliary cirrhosis, primary sclerosing cholangitis, intrahepatic cholestasis and liver injury, and in permitting the transmission and exchange of biological data genomics and proteomics data, the data generated from experimental biology, diseases data and patient clinical data ; scientific apparatus and instruments, namely sequencers being diagnostic readers of biomolecule and DNA sequence, genetic analyzer machines, biochips sensors for recording, treating, reproducing, transmitting data genomics and proteomics data, the data generated from experimental biology, diseases data and patient clinical data, in the field of clinical research and diagnostics of metabolic disorders and liver diseases non alcoholic related liver diseases: NAFLD (non alcoholic fatty liver disease) and non alcoholic steatohepatitis, alcoholic related liver disease: alcoholic steato hepatitis, liver fibrosis, hepatitis, cirrhosis, liver cancer, inherited diseases, primary biliary cirrhosis, primary sclerosing cholangitis, intrahepatic cholestasis and liver injury, for use in genetic and enzymatic research.


Classification kind code

11

Class [010]
Medical apparatus for identifying non alcoholic related liver diseases: NAFLD (non alcoholic fatty liver disease) and non alcoholic steatohepatitis, alcoholic related liver disease: alcoholic steato hepatitis, liver fibrosis, hepatitis, cirrhosis, liver cancer, inherited diseases, primary biliary cirrhosis, primary sclerosing cholangitis, intrahepatic cholestasis and liver injury, noninvasive diagnostic apparatus and instruments for detecting liver injury, being medical diagnostic apparatus, namely medical devices for diagnosis of liver diseases, blood analysis apparatus being blood analytes concentration measuring apparatus, DNA deoxyribonucleic acid and RNA ribonucleic acid analysis apparatus, gene analyzer being gene testing medical apparatus for identification and quantification of specific DNA and RNA sequences;


Classification kind code

11

Class [042]
Biological Biochemistry, biotechnological and biochemical research; clinical and medical research namely research and development of new pharmaceutical products for others, in the field of hepatic and metabolic diseases; computer programming and software design;


Classification kind code

11

Class [044]
Medical analysis services for the diagnosis of liver diseases non alcoholic related liver diseases: NAFLD (non alcoholic fatty liver disease) and non alcoholic steatohepatitis, alcoholic related liver disease: alcoholic steato hepatitis, liver fibrosis, hepatitis, cirrhosis, liver cancer, inherited diseases, primary biliary cirrhosis, primary sclerosing cholangitis, intrahepatic cholestasis and liver injury, metabolic diseases and disorders, obesity, type 2 diabetes, stroke, heart disease and cardiovascular disease, gastrointestinal diseases, inflammatory bowel diseases, inflammatory connective tissue diseases, autoimmune diseases and cancers; blood sample analysis services namely analysis and processing of blood plasma for others, being medical services; medical assistance services, namely, respite care services in the nature of nursing aid services; information services, namely providing medical information to third parties in the field of metabolic disorders and liver diseases.


Classification kind code

11

Mark Details


Serial Number

2044414

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 42
on 8th Jan 2025
Advertised
Submitted for opposition 26
on 11th Dec 2024
Approved
Submitted for opposition 27
on 11th Dec 2024
Approval Notice Sent
Submitted for opposition 22
on 5th Sept 2024
Search Recorded
Submitted for opposition 20
on 5th Sept 2024
Examiner's First Report
Submitted for opposition 67
on 15th Dec 2023
Agent Name Changed
Submitted for opposition 287
on 17th Jun 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 6th Aug 2020
Filed
Submitted for opposition 1
on 6th Aug 2020
Created
Submitted for opposition 31
on 6th Aug 2020
Formalized